Snapshot from May 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Simrit Parmar
Person

Simrit Parmar

Tracked across 1 events · 7 articles · First seen Apr 27, 2026 · Last active May 15, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Tech
Cellenkos CK0802 IND Clearance
Cellenkos, a clinical-stage biotechnology company, announced that the United States — Food and Drug Administration has cleared its Investigational New Drug (IND) application for CK0802. This clearance allows Cellenkos to initiate a Phase 1b/2a clinical…
Impact: Simrit Parmar, Founder of Cellenkos, commented on the significance of the United States — Food and Drug Administration clearance for CK0802, highlighting its potential for patients with steroid-refractory GVHD.
May 04, 2026 · 7 articles
NEWSDESK
Track Simrit Parmar live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.